Increased Interleukin-1 and lnterleukin-1 Receptor Antagonist Levels in Cervical Mucus in the Ovulatory Phase in Comparison with the Follicular Phase

Gynecologic and Obstetric Investigation

Volumn 43, Issue 3, 1997, Pages 166-170

  Kanai, Toshihito ^a   Fukuda Miki, Mariko ^a   Shimoya, Koichiro ^a   Azuma, Chihiro ^a   Hashimoto, Kazumasa ^a   Nobunaga, Toshikatsu ^a   Tokugawa, Yoshihiro ^a   Tsujimoto, Masahiko ^b   Saji, Fumitaka ^a   Murata, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA POLICE HOSPITAL   (Japan)

Author keywords

Cervical mucus; IL 1 receptor antagonist; Ovulation Interleukin 1

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; EPITHELIUM CELL; FEMALE; FOLLICULAR PHASE; HUMAN; IMMUNOHISTOCHEMISTRY; NORMAL HUMAN; OVULATION; PRIORITY JOURNAL; UTERINE CERVIX EPITHELIUM; UTERINE CERVIX MUCUS; UTERINE ENDOCERVIX;

ADULT; ANTIBODIES, MONOCLONAL; CERVIX MUCUS; CERVIX UTERI; EPITHELIUM; FEMALE; FOLLICULAR PHASE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; OVULATION; SIALOGLYCOPROTEINS;

EID: 15144344800     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000291847     Document Type: Article

References (28)

1. Dinarello CA: Interleukin-1 and interleukin-1 antagonism. Blood 1991;77:1627-1652.
2. Arend WP. Daycr JM: Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990:33:303-315.
3. Schwab JH. Änderte SK, Brown RR. Dalldorf FG, Thompson RC: Pro-and anli-inflammato-ry roles of intcrleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. Infect Immun 1991;59:4436-4442.
4. Griffin JD. Rambaldi A. Vellenga E. Young DC. Ostapovicz D. Canasta SA: Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony-stimulating factors. Blood 1987:70: 1218-1221.
5. Pistoia V. Cozzolino F. Rubartelli A. Torcia M. Roncclla S. Ferrarini M: In vitro production of interleukin-1 by normal and malignant human B lymphocytes. J Immunol 1986:136:1688-1692.
6. Mandrup-Poulscn T, Helqvist S. Molvig J. Wo-gensen LD. Nerup J: Cytokine as immune effector molecules in autoimmune endocrine with special reference to insulin-dependent diabetes mellitus. Autoimmunity 1989:4:191-218.
7. Ku G. Thomas CE, Akcson AL. Jackson RL: Induction of interleukin-lß expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadecanoic acid. J Biol Chem 1992;267:14183-14188.
8. Kariya M, Kanzaki H. Takakura K. Imai K. Okamoto N. Emi N. Kariya Y, Mori T: Inter-Icukin-I inhibits in vitro decidualization of human endometrial stromal cells. J Clin Endocrinol Metab 1991;73:1170-1174.
9. Fakih H, Baggett B, Holtz G. Tsang KY, Lee JC, Williamson HO: Interleukin-1: a possible role in the infertility associated with endometriosis. Fertil Steril 1987;47:213-217.
10. Hemsell DL. Nobles BJ. Heard MC. Hcmsellet PG: Upper and lower reproductive tract bacteria in 126 women with acute pelvic inflammatory disease. J Reprod Med 1988:33:799-805.
11. Hannunt CH, Wilcox CJ, Arend WP, Joslin FG. Dripps DJ. Hcimdal PL. Armes LG. Sommer A, Eisenberg SP. Thompson RC: lnterlcu-kin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 1990:343:336-339.
12. Eisenberg SP. Evans RJ, Arend WP, Verderber E. Brewer MT, Hannum CH, Thompson RC: Primary structure and functional expression from complementary DNA of a human inter-leukin-l receptor antagonist. Nature 1990:343: 341-346.
13. Carter DB, Dcibci MR. Dunn CJ, Tomichi CSC, Laborde AL, Slightom JL. Beiger AE, Bicnkowski MJ, Sun FF, McEwan RN. Harris PKW. Yem AW, Waszak GA. Chosay JG. Sieu LC, Hardee MM, Zurchcr-Ncely HA. Reardon IM, Hcinrikson RL, Truesdell SE, Shelly JA, Ecssalu TE. Taylor BM, Tracey DE: Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 1990:344:633-634.
14. Ohlsson K, Bjork P, Bergenfcldt M, Hageman R, Thompson RC: Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature 1990:348:550-552.
15. Wakabayashi G. Gelfand JA, Burke JF. Thompson RC. Dinarello CA: A specific receptor antagonist for interleukin-1 prevents Escherichia «»11-induced shock in rabbits. FA-SEBJ 1991:5:338-343.
16. Alexander HR. Doherty GM. Buresh CM. Venzon DJ, Norton JA: A recombinant human receptor antagonist to interleukin-1 improves survival after lethal endotoxemia in mice. J Exp Med 1991;173:1029-1032.
17. Cannon JG, Dinarello CA: Increased plasma interleukin-1 activity in women after ovulation. Science 1985:227:1247-1249.
18. Flynn A: Stimulation of interleukin-1 production from placental monocytes. Lymphokine Res 1984;3:1-5.
19. Naessens A, Foulon W, Debrucker P. Dcvrocy P. Lauwers S: Recovery of microorganisms in semen and relationship to semen evaluation. Fertil Steril 1986;45:101-105.
20. El-Dcmiry MIM. Young H, Elton RA. Har-greave TB, James K. Chisholm GD: Leukocytes in the ejaculate from fertile and infertile men. Br J Urol 1986:78:715-720.
21. Swenson CE, Toth A. Toth CL Wolfgruber L, O'Leary WM: Asymptomatic bacteriospermia in infertile men. Andrologia 1980;12:7-11.
22. Scckinger P. Lowcnthal JW, Williamson K. Dayer JM. MacDonald HR: A urine inhibitor of interleukin-1 activity that blocks ligand binding. J Immunol 1987;139:1546-1549.
23. Granowitz EV. Clark BD. Vannier E, Callahan MV, Dinarello CA: Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-l-induced cytokine synthesis and blocks the binding of IL-I to its type II receptor on human monocyte. Blood 1992;79:2356-2363.
24. Granowitz EV, Vannier E. Poutsiaka DD, Dinarello CA: Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: II. IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocyte. Blood 1992;79:2364-2369.
25. Seckingcr P. Klein-Nulend J. Alander C. Thompson RC, Dayer JM. Raisz LG: Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production. J Immunol 1990:145:4181-4184.
26. Arend WP. Welgus HG, Thompson RC, Eisen-berg SP: Biological properties of recombinant human monocyte-derived interleukin-1 receptor antagonist. J Clin Invest 1990:85:1694-1697.
27. Fischer E. Marano MA, Van Zee KJ. Rock AS, Hawes AS. Thompson WA, DeForge L, Kenny JS. Rcmick DG. Bloedow DC, Thompson RC, Lowry SF, Moldawcr LL: Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to suble-thal endotoxemia. J Clin Invest 1992:89:1551-1557.
28. Fukuda M, Azuma C, Kanai T, Koyama T, Kimura T, Saji F: Intcrlcukin-1 receptor antagonist expression in epithelial cells of human endometrium. Int J Gynaecol Obstet 1995;49: 305-310.